Dermatitis  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

402 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dermatitis
STADEH, NCT04274348: Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum

Recruiting
N/A
80
Europe
Skin biopsies and blood samples
Poitiers University Hospital
Atopic Dermatitis, Staphylococcus Aureus, Bacterial Toxins, Immune Response, Cytokines, T Cells Subsets
10/23
10/23
NCT00605878: Studies of Skin Microbes in Healthy People and in People With Skin Conditions

Recruiting
N/A
530
US
National Human Genome Research Institute (NHGRI)
Atopic Dermatitis, Eczema, Ichthyosis Vulgaris
 
 
NCT01164241: Natural History of Severe Allergic Inflammation and Reactions

Active, not recruiting
N/A
936
US
National Institute of Allergy and Infectious Diseases (NIAID)
PGM3 Deficiency, Eosinophilic and/or Atopic Dermatitis, OSMR Deficiency, Primary Localized Cutaneous Amyloidosis, Hereditary Alpha-tryptasemia
 
 
NCT05991674: A Prospective Study to Investigate Contact Sensitization Using Classic and Machine Learning Techniques

Recruiting
N/A
80
Europe
patch test for diagnosing allergic contact dermatitis
Andreas Syggros Hospital of Venereal and Dermatological Diseases
Allergic Contact Dermatitis
10/23
10/23
NCT04617977: Integrative Body-Mind-Spirit Intervention for Families With Children Suffering From Eczema

Recruiting
N/A
192
RoW
I-BMS for families with children suffering from eczema, Health education for parents whose children have eczema
The University of Hong Kong
Eczema, Dermatitis, Atopic
10/23
12/23
NCT05833880: Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis

Completed
N/A
89
Europe
Self-administered questionnaire
Central Hospital, Nancy, France
Atopic Dermatitis
08/23
08/23
HBOT, NCT06158347: Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients With Localized Breast Cancer

Recruiting
N/A
30
RoW
hyperbaric oxygen chamber
Ilsan Cha hospital
Breast Cancer, Radiation Dermatitis
12/24
12/24
DUPILAB, NCT06169527: A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab

Recruiting
N/A
500
Europe
Dupilumab, SAR231893, Dupixent®
Sanofi, Regeneron Pharmaceuticals
Atopic Dermatitis
11/27
11/27
ChiCTR2300069906: Risk assessment of asthma and atopic disease caused by assisted reproductive technology

Recruiting
N/A
4000
 
N/A ;N/A
Zhejiang University Medical College Affiliated Obstetrics and Gynecology Hospital; Women's Hospital, School of Medicine, Zhejiang University, 2021YFC2700603
asthma, atopic dermatitis and allergic rhinitis
 
 
NCT04662619: A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis

Active, not recruiting
N/A
273
Europe
B. infantis, Evivo, Lactose Placebo
Johnson & Johnson Consumer Inc. (J&JCI), Infinant Health, Inc. (formerly known as Evolve BioSystems, Inc.)
Healthy
12/23
11/24
PID, NCT05403762: Prevention of Incontinence-associated Dermatitis

Recruiting
N/A
210
Europe
ESENTAâ„¢ Skin Barrier Spray (ConvaTec, UK), Film-forming skin protectant, Hydrophobes Basisgel DAC, Hydrophobic skin protectant
Charite University, Berlin, Germany
Incontinence-associated Dermatitis
11/23
05/24
AD-BEASCUITS, NCT06192563: A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment

Recruiting
N/A
150
Europe
Dupilumab, SAR231893 (REGN668), Dupixent®
Sanofi
Dermatitis Atopic
01/26
01/26
NCT01782703: Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis

Recruiting
N/A
930
US
Northwestern University, Rockefeller University, Icahn School of Medicine at Mount Sinai
Atopic Dermatitis, Eczema
12/25
12/25
NCT02270411: Inflammatory Cells From Various Pathologies

Completed
N/A
95
Canada
Innovaderm Research Inc.
Atopic Dermatitis, Acne Rosacea, Acne Vulgaris
12/23
12/23
RADIOCREMVAL, NCT05886673: Development of a Protective Cream Against Radiodermatitis Caused by Radiotherapy.

Recruiting
N/A
5
Europe
experimental cream, standard of care
Antonio J. Conde Moreno, University of Valencia
Radiodermatitis
12/23
12/23
CetoSkin, NCT06194045: Nutritional Study to Determine the Effect of Fish Oil on Atopic Dermatitis

Recruiting
N/A
60
Europe
LC-MUFA oil, Placebo
Møreforsking AS, Helse Møre og Romsdal HF, Epax Norway AS, University of Manchester
Atopic Dermatitis
10/24
10/24
NCT06238765: CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

Enrolling by invitation
N/A
1500
US
CorEvitas
Atopic Dermatitis
12/99
12/99
CT-100-D-003, NCT06275659: An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis

Active, not recruiting
N/A
120
US
CT-100-004-A, CT-100-004-B
Click Therapeutics, Inc.
Psoriasis, Atopic Dermatitis
02/24
03/24
NCT05942248: The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis

Recruiting
N/A
1000
US
No Intervention
Integrative Skin Science and Research, Codex Labs
Acne, Melasma, Rosacea, Seborrheic Dermatitis
12/23
04/24
Derma-001, NCT06319781: A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo

Recruiting
N/A
370
Europe
Observational
Blueskin AS
Alopecia Areata, Vitiligo, Atopic Dermatitis, Psoriasis
05/25
05/25
TRIP, NCT04848194: Pleiotropic Role of TRPV1 in Psoriasis Inflammation

Completed
N/A
23
Europe
skin biopsy and blood sampling
University Hospital, Brest
Inflammation; Skin, Psoriasis
01/24
01/24
NCT05948306: Effects of Critical Patient-centered Skin Care Protocol

Enrolling by invitation
N/A
140
RoW
Critical Patient-Centered Skin Care Protocol
Istanbul Bilgi University, Istanbul University - Cerrahpasa (IUC)
Incontinence-associated Dermatitis, Pressure Injury
12/23
03/24
NCT03795506: TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)

Recruiting
N/A
96
Europe
Nocturnal Temperature controlled Laminar Airflow (TLA) Treatment, Placebo TLA Device
Imperial College London, JP Moulton Charitable Foundation
Atopic Dermatitis Eczema
12/24
05/25
NCT04276623: Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment

Recruiting
N/A
150
Europe
UMC Utrecht, Sanofi
Atopic Dermatitis
12/23
12/23
NCT05765461: Effect of Lipikar Baume AP+M on Quality of Life and Pain of Adults With Dryness or Severe Xerosis

Recruiting
N/A
3931
Europe, RoW
Cosmetique Active International
Atopic Dermatitis, Skin Diseases
12/23
12/23
NCT05971355: Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis

Recruiting
N/A
200
Europe
LimpiAD cream 2,5% plus, Vehicle, Emollient
Aileens Pharma SRL
Atopic Dermatitis
12/24
12/24
ERUDA, NCT05989932: Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis

Recruiting
N/A
350
Europe
Upadacitinib
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse
Atopic Dermatitis
12/23
11/31
ChiCTR2100054661: Comparative study on the efficacy and safety of 0.03% tacrolimus ointment and 2% Criborol ointment in the treatment of moderate atopic dermatitis in children

Not yet recruiting
N/A
120
 
0.03% tacrolimus ointment ;2% criborol ointment
West China Hospital of Sichuan University; West China Hospital of Sichuan University, Chinese Association of Rehabilitation Medicine
Atopic Dermatitis
 
 
NCT05330637: Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.

Recruiting
N/A
800
RoW
Climate and environment in Sanya
Shanghai Jiao Tong University School of Medicine
Asthma, Allergic Rhinitis, Chronic Obstructive Pulmonary Disease(COPD), Atopic Dermatitis, Eczema, Urticaria, Bronchitis, Bronchiectasis Adult, Emphysema
12/23
04/25
NCT05984420: Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis

Recruiting
N/A
200
Europe
LimpiAD 2,5% plus cream, Vehicle, Emollient
Aileens Pharma SRL, Advice Pharma Group srl
Atopic Dermatitis
12/24
12/24
ChiCTR2300068609: A single-center, randomized, parallel controlled clinical trial of mild multiplex sunscreen containing calendula extract (SPF50+ PA++++) for improving skin symptoms after sun exposure

Recruiting
N/A
200
 
Test on the left and control on the right ;Right subject sample left control sample
Beijing Children's Hospital Affiliated to Capital Medical University; Yunnan Botanee Bio-technology Group Co., Ltd., The sponsor
Atopic dermatitis(AD)
 
 
AbroSkib, NCT05140239: Effects of Abrocitinib Treatment on Skin Barrier Function

Recruiting
N/A
20
Europe
No Intervention
Prof. Dr. Stephan Weidinger
Atopic Dermatitis
12/23
12/24
ChiCTR2200063419: Study on the effect of Wei Rou nourishing and moisturizing essence cream on skin barrier parameters in patients with atopic dermatitis

Not yet recruiting
N/A
60
 
Velo moisturizing essence cream, for external use, 2 times a day, once in the morning and evening, evenly coated over the body and used at 250g every week. Basic therapy: mometasone furoate cream: applied once daily, after application of emollients in the evening, the lesion area is spread evenly, using ;Winona moisturizing cream, for external use, 2 times a day, once in the morning and evening, evenly coated over the body and used at 250g every week. Basic therapy: mometasone furoate cream: applied once daily, after application of emollients in the evening, the lesion area is spread evenly, using 1
Dermatology Hospital of Southern Medical University; Guangdong Cr.shunfeng Pharmaceutical Co., Ltd, Guangdong Cr.shunfeng Pharmaceutical Co., Ltd
Atopic dermatitis
 
 
ChiCTR2200063420: Clinical observation of the Wei Rou nourishing and moisturizing essence cream in adjuvant treatment of adults with atopic dermatitis

Not yet recruiting
N/A
60
 
Weirou nourishing and moisturizing essence cream, for external use, twice a day, once in the morning and once in the evening, evenly coated throughout the body, with a weekly dosage of 250 g. Basic treatment: cetirizine hydrochloride tablets: 1 to 7 days, orally, 10 mg/time, once a day at night. Des ;blank matrix, for external use, twice a day, once in the morning and once in the evening, evenly coated throughout the body, with a weekly dosage of 250 g. Basic treatment: cetirizine hydrochloride tablets: 1 to 7 days, orally, 10 mg/time, once a day at night, desonide cream: 1 to 21 days, t
Huashan Hospital of Fudan University; Guang Cr.shunfeng Pharmaceutical Co., Ltd, Guang Cr.shunfeng Pharmaceutical Co., Ltd
Atopic dermatitis
 
 
ChiCTR2200063423: Clinical observations of Shunfeng baby child moisturizing serum for children with atopic dermatitis

Not yet recruiting
N/A
60
 
Total body external application of Shunfeng baby child moisturizing essence + skin lesion site external use of corneodesmosin cream usage: apply cisfeng baby child moisturizing essence evenly throughout the body, twice a day (once in the morning and once in the evening, the dosage of each use should be ;Topical corneodesmosin on lesional sites Usage: the lesion sites were evenly applied with denaturing cream, 2 times a day (1 time each morning and evening), and 1 fingertip unit was used for each two palmar sized lesion areas. Note: apply Shunfeng baby child moisturizing serum first, followed by desonide
Shenzhen Maternity and Child Health Hospital; Guangdong Cr.shunfeng Pharmaceutical Co., Ltd, Guangdong Cr.shunfeng Pharmaceutical Co., Ltd
Atopic dermatitis
 
 
ChiCTR2200063845: Transcriptome characteristics of elderly atopic dermatitis in China

Recruiting
N/A
130
 
Nil ;Nil
Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College; Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, The Medicine and Health Technology Innovation Project of Chinese Academy of Medical Sciences
Atopic dermatitis
 
 
NCT05688735: Assessment of the Effect of Coconut and Sunflower Seed Oil Derived Isosorbide Diseters and Colloidial Oatmeal

Recruiting
N/A
40
US
Isosorbide Diester Moisturizer, Control Moisturizer
Integrative Skin Science and Research, Sytheon Ltd.
Atopic Dermatitis
12/23
03/24
NCT05561803: The Use of Photobiomodulation in the Management of Radiodermatitis in Patients in Palliative Care. A Prospective Study.

Withdrawn
N/A
40
RoW
Photobiomodulation Therapy, PBM Therapy
University of Nove de Julho
Radiodermatitis; Acute, Radiotherapy Side Effect, Cancer Patients, Palliative Care
07/24
12/24
NCT04341623: Xerosis and Use of Topical Moisturizer

Active, not recruiting
N/A
35
US
Cetaphil Pro Eczema moisturizer, Electronic interaction, GPSkin
Wake Forest University Health Sciences, Galderma R&D
Xerosis Due to Atopic Dermatitis
11/24
12/24

Recruiting
N/A
318
Europe
Topical corticosteroids, Systemic cyclosporine, Neoral, Systemic dupilumab, DUPIXENT
Erasmus Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development
Dermatitis, Atopic
01/24
01/25
NCT05858723: Repeated Open Application Test (ROAT) Study With Hydroperoxides of Linalool

Not yet recruiting
N/A
40
NA
ROAT, Patch testing and punch biopsies
National Allergy Research Center, Denmark
Allergic Contact Dermatitis
01/24
07/24
AZI_IMQ_LPS, NCT06170983: Skin Inflammation and PK of Azithromycin

Not yet recruiting
N/A
36
NA
Azithromycin, Biopsy, Skin inflammation model
Medical University of Vienna
Skin Infection
01/26
07/26
NCT03962387: Evalution the Safety and Efficacy in Atopic Dermatitis Patients

Active, not recruiting
N/A
98
RoW
Not applicable(observational study)
Kang Stem Biotech Co., Ltd.
Atopic Dermatitis
01/24
01/24
NCT06268847: Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms

Recruiting
N/A
108
Europe
Placebo, ACT01, ACT02
Abyss Ingredients, Eurofins
Atopic Dermatitis, Eczema
06/24
06/24
VR-DERMA, NCT06182436: Virtual Reality for Pain Management During Dupilumab Injection

Not yet recruiting
N/A
98
Canada
Virtual Reality Distraction, Standard Treatment
St. Justine's Hospital
Atopic Dermatitis, Pain, Anxiety
09/24
03/25
RESET, NCT06136767: Registry for Systemic Eczema Treatments

Recruiting
N/A
400
US
Johns Hopkins University, Doris Duke Charitable Foundation
Atopic Dermatitis
08/26
12/26
ChiCTR2300067459: Shenling Baizhu powder can inhibit inflammation and improve the progression of atopic dermatitis by claudin-1 /MyD88 signal

Not yet recruiting
N/A
60
 
Shenling Baizhu powder ;Loratadine Tablets
Affiliated Hospital of Hebei University of Technology; Affiliated Hospital of Hebei University of Technology, Project of Hebei Administration of Traditional Chinese Medicine
Atopic dermatitis
 
 
EPOXY, NCT05891743: Prevalence of Skin Sensitization and Dermatitis Among Epoxy-exposed Workers in the Wind Turbine Industry.

Recruiting
N/A
150
Europe
Patch Test
Siemens Gamesa Renewable Energy Blades, S.A., Association for Innovation and Biomedical Research on Light and Image
Dermatitis
08/24
08/24
ChiCTR2300068628: Effect of intervention based on temporal self-regulation theory on self-management of radiodermatitis in breast cancer patients

Recruiting
N/A
64
 
Routine care ;Intervention measures based on temporal self-regulation theory
The First Affiliated Hospital of Dalian Medical University; The First Affiliated Hospital of Dalian Medical University, None
Breast cancer
 
 
ChiCTR2300068720: Evaluation of clinical pharmacists implementing standardized drug therapy management services for patients with moderate to severe atopic dermatitis

Not yet recruiting
N/A
438
 
Receive 12 weeks of standardized MTM services led by clinical pharmacists ;no
shanghai skin disease hospital; shanghai skin disease hospital, Zhongguancun Help Bang Medical health Technology Innovation Center
atopic dermatitis
 
 
NCT05535452: Photobiomodulation for Prevention of Radiodermatitis in Women With Breast Cancer Undergoing Adjuvant Radiotherapy

Not yet recruiting
N/A
148
NA
Photobiomodulation through LED board, Light emitting diode
Instituto Nacional de Cancer, Brazil
Radiodermatitis
02/24
02/25
NCT06300697: Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project

Recruiting
N/A
200
US
Data and biospecimen collection, Skin biopsies, Oral Food Challenge (OFC) procedures
University of Michigan
Atopic Dermatitis, Food Allergy, Healthy
03/27
03/27
NCT06003764: Efficacy of Pulsed Electromagnetic Field Therapy on Acute Radiodermatitis in Breast Cancer Patients

Recruiting
N/A
50
RoW
Pulsed electromagnetic field, traditional skin care
Ahram Canadian University
Dermatitis, Radiation Induced
02/24
03/24
NCT04764682: Determining Molecular Drivers of Radiation Dermatitis

Active, not recruiting
N/A
20
US
Mayo Clinic
Breast Cancer
02/25
02/25
NCT05575882: Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream Intended for Very Dry, Irritated to Atopic Sensitive Skin.

Recruiting
N/A
100
RoW
Skin hydration, Corneometer, Barrier function measurement, Transepidermal Water Loss (TEWL), Potential of hydrogen measurement (pH), Clinical evaluation of atopic dermatitis, Eczema Area and Severity Index (EASI), Quality of life assessment, Assessment of the effect on itching and sleep disturbances, Assessment of the tolerance of the study product or placebo
NAOS Argentina S.A.
Atopic Dermatitis, Eczema, Atopic
03/24
05/24
AD-TPE, NCT04352270: Clinic-Based Atopic Dermatitis Therapeutic Patient Education

Completed
N/A
56
US
AD printed educational materials, AD educational videos
Boston University
Atopic Dermatitis
09/23
09/23
TOPIAbis, NCT06108570: Evaluation of the Efficacy of TOPIALYSE Baume Protect+ on Atopic Dermatis

Not yet recruiting
N/A
72
NA
Cosmetic Product TOPIALYSE Baume Protect+, Cosmetic product Neutral Product
SVR Group
Atopic Dermatitis
03/24
05/24
DIAhR, NCT06213688: Involvement of Pollutants in Atopic Dermatitis and Psoriasis

Not yet recruiting
N/A
64
NA
blood sampling, urine sampling
Assistance Publique Hopitaux De Marseille, ALPHENYX, Aix Marseille Université
Psoriasis, Atopic Dermatitis
03/25
03/25
DEVISE, NCT06324695: Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases

Not yet recruiting
N/A
550
Europe
HautKompass
Universitätsklinikum Hamburg-Eppendorf, German Federal Ministry of Education and Research
Psoriasis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Atopic Dermatitis
09/24
03/25
NCT06191627: Patient Experience and Quality of Patch Testing on the Legs vs Back

Recruiting
N/A
30
US
Patch testing
HealthPartners Institute
Allergic Contact Dermatitis
06/24
06/24
NCT05437887: Effects of Fucoidan on the Gut Microbiota in the Patients of Atopic Dermatitis

Recruiting
N/A
40
RoW
Fucoidan
Chang Gung Memorial Hospital
Atopic Dermatitis
03/24
03/24
EMD-U vs CAU, NCT06427122: Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life

Recruiting
N/A
120
Europe
EMD Protocol for Urge, Care as Usual
Tamar Nijsten
Atopic Dermatitis, Prurigo Nodularis
03/26
05/26
DECODE-Scratch, NCT06448689: Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and Psoriasis

Recruiting
N/A
90
Europe
ActiGraph L.L.C
Atopic Dermatitis, Psoriasis
03/26
06/26
SMECA, NCT06124781: Molecular Diagnosis of Allergic Contact Dermatitis ().

Recruiting
N/A
60
Europe
Blood sample, Skin biopsies, ROAT test
Ramsay Générale de Santé, Institut National de la Santé Et de la Recherche Médicale, France
Eczema, Allergic Contact Eczema Nos
03/24
12/24
NCT04170244: Study of Skin Microbiome in AD and PS Patients

Recruiting
N/A
240
US
AD subject visit sampling procedures, PS subject visit sampling procedures, Healthy control visit sampling procedures
University of Rochester
Atopic Dermatitis, Psoriasis
04/26
04/26
NCT05443490: Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in Children

Recruiting
N/A
150
Europe
Probiotic mixture with three bacterial strains with maltodextrin as a carrier., Placebo comparator with maltodextrin as a carrier.
Bionou Research, S.L., Biopolis S.L.
Atopic Dermatitis
12/24
03/25
ATTRACT, NCT06353087: Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis ( Registry)

Not yet recruiting
N/A
200
NA
Pfizer
Dermatitis, Atopic, Dermatitis, Eczema, Skin Diseases, Immune System Diseases, Janus Kinase Inhibitors
11/25
11/25
NCT06331390: Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis

Recruiting
N/A
25
RoW
niacinamide cosmetic product, placebo
University of Split, School of Medicine
Contact Dermatitis
06/24
07/24
PatchCam, NCT06351449: Characterization of Visual Characteristics in Allergic Contact Dermatitis Using the Skincam® Tool

Not yet recruiting
N/A
500
NA
The patch under study is photographed using the SkinCam®
Hospices Civils de Lyon
Allergic Contact Dermatitis
04/27
04/27
NCT06387212: 35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Inflammation of Skin

Recruiting
N/A
20
RoW
35 kDa hyaluronan fragment HA35 injection, HA35
Nakhia Impex LLC
Skin Inflammation, Cosmetic Skin
05/24
05/24
NCT06363786: Reducing Skin Surface pH During Skin Occlusion: Changes to Skin Microbiome and Skin Parameters

Active, not recruiting
N/A
24
Europe
Test patches
Essity Hygiene and Health AB
Incontinence-associated Dermatitis
05/24
09/24
STADE, NCT04715087: Staphylococcus Aureus in Atopic Dermatitis Immunopathology

Recruiting
N/A
20
Europe
Blood sample (Day -42 to Day -28, Day 3),Skin swab sampling (Day -42 to Day -28, Day 0, Day 13) , patch test application (Day 0) , skin biopsies (Day 13), Blood sample (Day 0 ,Day 3),Skin swab sampling (Day 0,Day 13), patch test application (Day 1), skin biopsies (Day 13)
Hospices Civils de Lyon
Atopic Dermatitis
04/25
06/26
ProRaD, NCT04240522: Prospective Longitudinal Observational Research in Atopic Dermatitis

Recruiting
N/A
1000
Europe
University of Zurich, University of Bonn
Atopic Dermatitis, Asthma, Atopic Dermatitis and Related Conditions
04/24
04/24
ChiCTR2300071808: A Multicenter, Randomized Controlled Study of TDX105 Granules in the Treatment of Radiation Dermatitis

Not yet recruiting
N/A
120
 
TDX105 granules + basic therapy ;Hirudoid cream + basic therapy
Beijing Hospital of TCM, Capital Medical University; Tasly Pharmaceutical Group Co., LTD, Tasly Pharmaceutical Group Co., LTD
radiation dermatitis
 
 
RASH, NCT04763512: Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)

Recruiting
N/A
200
RoW
Intact Cow's Milk Protein Formula, Partially Hydrolysed Whey Formula
Société des Produits Nestlé (SPN), Medidata Solutions, SAS Institute, Veeva Systems, Cognizant Technology Solutions AG
Atopic Dermatitis, Skin Condition
05/24
06/24
NCT06370637: Efficacy of Cream for Moisture Associated Skin Damage From Fecal Incontinence and/or Diarrhea

Not yet recruiting
N/A
40
NA
MASD Control Arm
Scotiaderm
Incontinence-associated Dermatitis, Moisture Associated Skin Damage (MASD) (E.G., Incontinence-Associated Dermatitis [IAD], Perspiration, Drainage), Fecal Incontinence Incontinence-associated Dermatitis
05/25
05/26
NCT06387472: DermAI to Evaluate Human Factor of Testing

Recruiting
N/A
150
US
AI algorithm to evaluate photographs of skin test patch regions, DermAI, Allergen Patch
Mayo Clinic
Contact Dermatitis
08/24
12/24
Vahvistu, NCT06390878: Nationwide Research on the Rewilding of Kindergarten Yards

Recruiting
N/A
320
Europe
Biodiversity, Playground equipment
Natural Resources Institute Finland, Tampere University
Microbial Colonization, Atopic Dermatitis, Asthma in Children, Allergy, Cognitive Change, Respiratory Infection, Nature, Human
08/27
08/27
NCT06032403: Patient With Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred Consultations

Recruiting
N/A
200
Europe
flexible patient centred consultations
University Hospital, Gentofte, Copenhagen, Aage Bangs Fond, The Novo Nordic Foundation, Herlev and Gentofte Hospital, Sanofi, Almirall, S.A.
Atopic Dermatitis
05/24
06/25
ChiCTR2300071085: Study on intelligent discrimination of psoriasis and atopic dermatitis based on multimodal data

Not yet recruiting
N/A
200
 
None
Beijing Hospital; Beijing Hospital, Beijing Hospital Medical Engineering Special Project/Beijing Hospital Biomedical frontier interdisciplinary team Project
Psoriasis and atopic dermatitis
 
 
PROADAP, NCT06415175: Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain

Not yet recruiting
N/A
150
NA
Dupilumab
Sanofi, Regeneron Pharmaceuticals
Atopic Dermatitis
09/26
09/27
Dermatitis, NCT05078294: Results in Real Clinical Practice of Treatment of Moderate-severe Atopic

Recruiting
N/A
300
Europe
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Dermatitis, Atopic
06/24
11/24
ChiCTR2200061072: A randomized controlled trial of “structural stress regulation group therapy” in patients with atopic dermatitis

Not yet recruiting
N/A
32
 
structural stress regulation group therapy
The Second Affiliated Hospital of Guangzhou Medical University; The Second Affiliated Hospital of Guangzhou Medical University, The Second Affiliated Hospital of Guangzhou Medical University
atopic dermatitis
 
 
ChiCTR2300071972: Single-center randomized open two-preparation, two-sequence and two-cycle crossover bioequivalence trial of claborol ointment (specification: 30g/2%) given topically in Chinese healthy volunteers on an empty stomach

Not yet recruiting
N/A
28
 
In the first cycle, the subject applied the test preparation on an empty stomach;The second cycle of cross administration after 4 days ;In the first cycle, the subject applied the reference preparation on an empty stomach;The second cycle of cross administration after 4 days
Shulan(Hangzhou) Hospital; Jiangxi Kerui Pharmaceutical Co., Ltd, Jiangxi Kerui Pharmaceutical Co., Ltd.
Atopic dermatitis
 
 
NCT06221046: Clinical Trial Cream D

Not yet recruiting
N/A
30
NA
Cream D, Control
Scotiaderm
Incontinence-associated Dermatitis, Moisture Associated Skin Damage (MASD) (E.G., Incontinence-Associated Dermatitis [IAD], Perspiration, Drainage), Intertrigo
06/25
06/25
NCT06454942: Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individuals

Not yet recruiting
N/A
44
NA
Nutrient-fortified egg, Regular egg with habitual diet
National University of Singapore, National University Hospital, Singapore, Ministry of Education, Singapore
Atopic Dermatitis Eczema, Aging, Diet Modification
11/25
05/26
MYCAH, NCT06455891: MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement

Not yet recruiting
N/A
45
Europe
Assistance Publique - Hôpitaux de Paris
Atopic Dermatitis
06/25
06/25
NCT06178289: Effectiveness of 3M Cavilon Advanced Skin Protectant in the Treatment of Moisture-associated Skindamage in Nursinghomes

Recruiting
N/A
36
Europe
3M Cavilon Advanced Skin Protectant, cyanoacrylate based film, Standard nursing home treatment protocol
University Ghent, 3M
Irritant Dermatitis, Stoma Site Dermatitis, Wound of Skin
10/24
02/25
ChiCTR2300071253: Clinical and therapeutic mechanism of bezoar repair oil in treating atopic dermatitis of head and neck

Not yet recruiting
N/A
60
 
Traditional Chinese medicine oil for external use ;Camellia oil, the substrate of topical Chinese medicine oil ;None ;None
Guangdong Provincial Hospital of Traditional Chinese Medicine (The Second Clinical Medical College of Guangzhou University of Traditional Chinese Medicine); The Second Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, The Second Clinical Medical College of Guangzhou University of Chinese Medicine
atopic dermatitis
 
 
REACH-AD, NCT06421740: An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China

Recruiting
N/A
1000
RoW
AbbVie
Atopic Dermatitis
06/26
06/26
NCT06463353: Clinical Study of Trilinolein Cream for Prevention of Relapse in Remission of Moderate-to-severe Atopic Dermatitis.

Not yet recruiting
N/A
376
NA
trilinolein cream group, cream base group
Shanghai Yueyang Integrated Medicine Hospital
Atopic Dermatitis
06/27
11/27
NCT05442645: A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in Taiwan

Active, not recruiting
N/A
80
RoW
Sanofi
Atopic Dermatitis
06/24
06/24
NCT05792826: Clinical Study of BSZY Cream Intervention to Relieve Atopic Facial Dermatitis

Recruiting
N/A
130
RoW
BSZY Cream, emulsion matrix
Shanghai Yueyang Integrated Medicine Hospital
Atopic Dermatitis of Face (Diagnosis)
06/24
06/24
NCT06474728: Effects of an Emollient Containing Postbiotic Saccharomyces and Lactobacillus on Pediatric Atopic Dermatitis

Not yet recruiting
N/A
98
NA
Treatment with an Emollient Containing Postbiotic Saccharomyces and Lactobacillus
Children's Hospital of Fudan University
Atopic Dermatitis, Eczema, Emollient
09/25
12/25
NCT05319444: Cleansing Device for the Treatment of Scalp and Hair Conditions

Recruiting
N/A
40
US
Off-brand Waterpik®
University of Minnesota
Dandruff, Seborrheic Dermatitis, Hair Loss
07/24
07/24
NCT06244212: Topical Treatment for Atopic Dermatitis

Not yet recruiting
N/A
30
US
Demonstration of applying triamcinolone cream, Mobile App Use, Standard of Care
Wake Forest University Health Sciences
Atopic Dermatitis
11/24
08/25
NCT04614753: Dealcoholized Muscadine Wine and Skin Health in Women

Active, not recruiting
N/A
20
US
Dealcoholized Muscadine Wine, Control Beverage
University of Florida
Skin Health
07/24
07/24
HKWC-2024-295, NCT06448702: Evaluation of Efficacy and Safety of Enhanced External Counter-pulsation on Patients With Atopic Dermatitis and Inflammatory Skin Disease Requiring Wet Wrap Therapy

Not yet recruiting
N/A
40
NA
wet wrap therapy, External compression counter-pulsation (EECP)
The University of Hong Kong
Atopic Dermatitis, Inflammatory Skin Disease
12/24
12/25
NCT06464133: Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis

Not yet recruiting
N/A
300
NA
University of Pennsylvania
Atopic Dermatitis, Eczema
12/27
12/27
CAN UpTIMISE, NCT05394792: An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab

Recruiting
N/A
100
Canada
AbbVie
Atopic Dermatitis
05/24
05/24
 

Download Options